NCT07220590 Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy
| NCT ID | NCT07220590 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oregon Health and Science University |
| Condition | Cerebral Palsy Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-10-01 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a therapist training program can help providers in Part C Early Childhood Settings use powered mobility (PM) with young children who have cerebral palsy (Gross Motor Function Classification System Levels IV-V). The study will also look at whether this training is practical and useful for therapists, families, and children. The main questions it aims to answer are: 1. Can therapists successfully use the training to provide powered mobility interventions in home and early childhood settings? 2. Do families and children find the intervention acceptable and helpful? 3. What benefits do children show in mobility, participation, and engagement after using powered mobility? In this study, therapists and families will: 1. Take part in a training program about how to use powered mobility with young children 2. Use powered mobility devices (Permobil Explorer Mini) with children during everyday routines 3. Complete surveys, interviews, and observations about their experiences
Eligibility Criteria
Inclusion Criteria: Children: 1. Diagnosis of cerebral palsy or similar motor impairment 2. Gross Motor Function Classification System (GMFCS) Levels IV-V 3. Age 12 to 32 months at enrollment 4. Enrolled in early intervention services Caregivers: 1. Parent or legal guardian of an enrolled child participant 2. Age 18 years or older 3. English- or Spanish-speaking 4. Able and willing to participate in home-based data collection, including caregiver coaching sessions, completion of surveys, and video-recorded sessions 5. Able to provide informed consent Therapists: 1. Licensed physical therapist or occupational therapist 2. Employed at participating early intervention or early childhood special education settings 3. Provide services to children with cerebral palsy or motor delays 4. No prior powered mobility intervention training required 5. Willing to complete powered mobility implementation training and participate in study assessments Exclusion Criteria: 1. Inability or unwillingness to provide informed consent 2. Inability to complete required study procedures
Contact & Investigator
Bethany M Sloane, PT, DPT, PhD
PRINCIPAL INVESTIGATOR
Oregon Health and Science University
Frequently Asked Questions
Who can join the NCT07220590 clinical trial?
This trial is open to participants of all sexes, aged 12 Months or older, studying Cerebral Palsy Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07220590 currently recruiting?
Yes, NCT07220590 is actively recruiting participants. Contact the research team at sloaneb@ohsu.edu for enrollment information.
Where is the NCT07220590 trial being conducted?
This trial is being conducted at Hillsboro, United States, Portland, United States, Portland, United States.
Who is sponsoring the NCT07220590 clinical trial?
NCT07220590 is sponsored by Oregon Health and Science University. The principal investigator is Bethany M Sloane, PT, DPT, PhD at Oregon Health and Science University. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.